The results revealed that the core prescriptions are involved in three major biological processes, tumor apoptosis, angiogenesis, and immune anti-inflammatory effects, through 15 main active ingredients and 16 potential targets and that the prescriptions activated the following pathways: signaling by ILs [22], MAPK signaling, and VEGF signaling. The gene discussed is VEGFA; the disease is neoplasm.